financetom
Business
financetom
/
Business
/
Form 8.3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Form 8.3
Nov 7, 2025 5:27 AM

LONDON--(BUSINESS WIRE)--

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Qube Research & Technologies Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

AMERICAN AXLE & MANUFACTURING HOLDINGS, INC.

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

06-11-2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

DOWLAIS GROUP PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

USD 0.01 common

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.00

3,908,671

3.29

(2) Cash-settled derivatives:

 

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

0

0.00

3,908,671

3.29

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

0

Details, including nature of the rights concerned and relevant percentages:

0

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit (USD)

USD 0.01 common

Purchase

3400

6.16

USD 0.01 common

Purchase

2643

6.16

USD 0.01 common

Purchase

2859

6.17

USD 0.01 common

Purchase

300

6.17

USD 0.01 common

Purchase

927

6.18

USD 0.01 common

Purchase

304

6.19

USD 0.01 common

Purchase

1433

6.20

USD 0.01 common

Purchase

4463

6.21

USD 0.01 common

Purchase

3681

6.22

USD 0.01 common

Purchase

2999

6.23

USD 0.01 common

Purchase

2100

6.24

USD 0.01 common

Purchase

241

6.25

USD 0.01 common

Sale

16009

6.17

USD 0.01 common

Sale

300

6.23

USD 0.01 common

Sale

575

6.24

USD 0.01 common

Sale

396

6.26

USD 0.01 common

Sale

330

6.27

USD 0.01 common

Sale

225

6.34

USD 0.01 common

Sale

1000

6.37

USD 0.01 common

Sale

236

6.39

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. call option

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of securities

Exercise price per unit (GBp)

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit (GBp)

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit
(GBp)

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

0

0

0

0

 

0

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

0

 

0

0

0

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

None

 

(c) Attachments

Class of relevant security:

 

USD 0.01 common

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.00

3,908,671

3.29

(2) Cash-settled derivatives:

 

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

0

0.00

3,908,671

3.29

0

Class of relevant security:

 

USD 0.01 common

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

0

0.00

3,908,671

3.29

(2) Cash-settled derivatives:

 

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

0

0.00

3,908,671

3.29

1

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Source: Qube Research & Technologies LTD

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Autolus Therapeutics Says Leukemia Drug Aucatzyl Gets EU Marketing Approval
Autolus Therapeutics Says Leukemia Drug Aucatzyl Gets EU Marketing Approval
Jul 21, 2025
07:42 AM EDT, 07/21/2025 (MT Newswires) -- Autolus Therapeutics ( AUTL ) said Monday that the European Commission has issued marketing authorization for Aucatzyl to treat patients 26 years and older with relapsed or refractory B-cell precursor acute lymphoblastic leukemia. The approval was based on the results of a clinical study published in November 2024, the company said, adding it...
Avantor Names Emmanuel Ligner CEO
Avantor Names Emmanuel Ligner CEO
Jul 21, 2025
07:42 AM EDT, 07/21/2025 (MT Newswires) -- Avantor ( AVTR ) said Monday it has appointed Emmanuel Ligner as its chief executive officer and president, effective Aug. 18. Ligner succeeds Michael Stubblefield, who will step down as CEO, president and director following Ligner's appointment, the company said. Ligner was previously Cerba HealthCare's CEO, Avantor ( AVTR ) added. ...
Roper Technologies raises annual forecasts on strong software demand
Roper Technologies raises annual forecasts on strong software demand
Jul 21, 2025
July 21 (Reuters) - Roper Technologies ( ROP ) raised its forecasts for annual revenue and adjusted profit on Monday, betting on resilient enterprise spending on its vast portfolio of software products amid macroeconomic uncertainty. With businesses grappling with a shifting trade landscape following President Donald Trump's tariffs, spending on Roper's products has stayed strong as the company provides critical...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved